In:
Cancer, Wiley, Vol. 120, No. 15 ( 2014-08), p. 2299-2307
Abstract:
In this study, the incidence of a Bim deletion polymorphism is approximately 13%, and it is associated with a poor clinical response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in Chinese patients who have EGFR mutations.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v120.15
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink